BioNTech Says Experimental Breast Cancer Drug Succeeded in Trial

BioNTech SE said an experimental drug succeeded in a breast cancer study, the first dividend of the German Covid-19 vaccine maker’s collaboration with Chinese biotech Duality Biotherapeutics Inc....

Redirecting to full article...